BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33497503)

  • 1. The diagnostic value of p63, p16, and p53 immunohistochemistry in distinguishing seborrheic keratosis, actinic keratosis, and Bowen's disease.
    Nasiri S; Azhari V; Bidari-Zerehpoosh F; Asadi-Kani Z; Talebi A
    Dermatol Ther; 2021 Mar; 34(2):e14817. PubMed ID: 33497503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical staining for p16 is a useful adjunctive test in the diagnosis of Bowen's disease.
    Harvey NT; Leecy T; Wood BA
    Pathology; 2013 Jun; 45(4):402-7. PubMed ID: 23635817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p16 immunostaining in keratinocytic neoplasia in organ transplant recipients: Bowen's disease shows a characteristic pattern.
    Genders RE; Beck S; Bouwes Bavinck JN; van den Munckhof HA; Kouwenhoven ST; de Koning MN; de Gruijl FR; Jenkins D; Willemze R; Quint KD
    J Cutan Pathol; 2017 Jan; 44(1):28-33. PubMed ID: 27717097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of p53 and p16 in actinic keratosis, bowenoid actinic keratosis and Bowen's disease.
    Bagazgoitia L; Cuevas J; Juarranz A
    J Eur Acad Dermatol Venereol; 2010 Feb; 24(2):228-30. PubMed ID: 19515076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical intraepidermal keratinocytic lesions falling short of carcinoma in situ (Bowen disease) on routine staining: the utility of p16 immunostaining.
    Ko C; Srisuttiyakorn C
    J Cutan Pathol; 2014 Dec; 41(12):975-7. PubMed ID: 25558038
    [No Abstract]   [Full Text] [Related]  

  • 6. Ki-67 and p16 Immunostaining Differentiates Pagetoid Bowen Disease From "Microclonal" Seborrheic Keratosis.
    Bahrani E; Sitthinamsuwan P; McCalmont TH; Pincus LB
    Am J Clin Pathol; 2019 May; 151(6):551-560. PubMed ID: 30852607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin.
    Saglam O; Salama M; Meier F; Chaffins M; Ma C; Ormsby A; Lee M
    Am J Dermatopathol; 2008 Apr; 30(2):123-6. PubMed ID: 18360114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p16INK4a expression in actinic keratosis and Bowen's disease.
    Salama ME; Mahmood MN; Qureshi HS; Ma C; Zarbo RJ; Ormsby AH
    Br J Dermatol; 2003 Nov; 149(5):1006-12. PubMed ID: 14632806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative histochemical study of Bowen's disease and actinic keratosis: preserved normal basal cells in Bowen's disease.
    Ishida H; Kumakiri M; Ueda K; Lao LM; Yanagihara M; Asamoto K; Imamura Y; Noriki S; Fukuda M
    Eur J Histochem; 2001; 45(2):177-90. PubMed ID: 11512639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different Immunohistochemical Localization of Fatty Acid Binding Protein 5 in Actinic Keratosis Compared with That in Bowen's Disease: A Retrospective Study.
    Ahn B; Kim CH; Chae YS; Lee JH; Lee Y; Ahn HH; Lee YJ
    Am J Dermatopathol; 2021 May; 43(5):356-361. PubMed ID: 33055535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of P27, Ki67 and P53 in squamous cell carcinoma, actinic keratosis and Bowen disease.
    Talghini S; Halimi M; Baybordi H
    Pak J Biol Sci; 2009 Jun; 12(12):929-33. PubMed ID: 19777788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal highlights: Clonal seborrheic keratoses often demonstrates p16 expression.
    Omman RA; Speiser J; Robinson S; Lapadat R; Mudaliar K
    J Cutan Pathol; 2019 Jun; 46(6):411-417. PubMed ID: 30828837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An assessment of the malignant potential of actinic keratoses and Bowen's disease: p53 and PCNA expression pattern correlate with the number of desmosomes.
    Ramzi ST; Maruno M; Khaskhely NM; Khan MA; Takamiyagi A; Uezato H; Nonaka S
    J Dermatol; 2002 Sep; 29(9):562-72. PubMed ID: 12392064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS.
    Azimi A; Kaufman KL; Ali M; Arthur J; Kossard S; Fernandez-Penas P
    J Dermatol Sci; 2018 Jul; 91(1):69-78. PubMed ID: 29665991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of p63 and cyclooxygenase-2 and their correlation in skin tumors.
    Wu Y; Liu H; Li J
    J Huazhong Univ Sci Technolog Med Sci; 2007 Apr; 27(2):206-8. PubMed ID: 17497299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
    Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
    Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of p63 in actinic keratoses, seborrheic keratosis, and cutaneous squamous cell carcinomas.
    Wrone DA; Yoo S; Chipps LK; Moy RL
    Dermatol Surg; 2004 Oct; 30(10):1299-302. PubMed ID: 15458526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
    Sakiz D; Turkmenoglu TT; Kabukcuoglu F
    Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression profiles of p63, p53, survivin, and hTERT in skin tumors.
    Park HR; Min SK; Cho HD; Kim KH; Shin HS; Park YE
    J Cutan Pathol; 2004 Sep; 31(8):544-9. PubMed ID: 15268709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The characteristics of human papillomavirus expression and cell proliferation in actinic keratosis and Bowen's disease of the skin.
    Kvlividze O; Gogiashvili L; Burkadze G
    Georgian Med News; 2006 Jul; (136):108-12. PubMed ID: 16905862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.